ClinicalTrials.Veeva

Menu

Treatment for Aerobic Vaginitis by Using Bofukang Vaginal Suppository

P

Peking University

Status and phase

Enrolling
Phase 3

Conditions

Vaginitis

Treatments

Drug: Experimental: Baofukang Suppository 7 days
Drug: Experimental: Baofukang Suppository 14 days

Study type

Interventional

Funder types

Other

Identifiers

NCT04574089
PUShenzhenH

Details and patient eligibility

About

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.To evaluate the efficacy and safety after treatment.

Full description

Aerobic vaginitis was treated by using Baofukang Suppository 7 days group or Baofukang Suppository 14 days group.

Group 1: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 7 days.

Group 2: Baofukang Suppository (1.74g), for vaginal use, 2 capsules per night for 14 days.

The efficacy and safety will be evaluated 7~14 days after treatment and 35~42 days after treatment.

Enrollment

50 estimated patients

Sex

Female

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Aerobic vaginitis diagnosed based on present :

  1. Vaginal dischareg ;
  2. pH > 4.5;
  3. Donders score≥3;

Exclusion criteria

  1. Patients with other vaginitis, cervical erosion, or suspected gonorrhea, herpes simplex virus infection and other vulvar diseases;
  2. Patients received systemic or vaginal antifungal or antibiotic treatment within two weeks before admission.
  3. Pregnancy, lactation and intentional pregnancy;
  4. Women with liver and kidney dysfunction, low immune function, diabetes, psychosis or other serious diseases;
  5. Allergic constitution and patients allergic to drug ingredients in this study;
  6. Those with poor compliance.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups

Baofukang Suppository 7 days
Experimental group
Description:
Baofukang Suppository (1.74g), for vaginal external use, 2 capsules per night for 7 days
Treatment:
Drug: Experimental: Baofukang Suppository 7 days
Baofukang Suppository 14 days
Experimental group
Description:
Baofukang Suppository (1.74g), for vaginal external use, 2 capsules per night for 14days
Treatment:
Drug: Experimental: Baofukang Suppository 14 days

Trial contacts and locations

1

Loading...

Central trial contact

Yiheng Liang, M.D.; Ping Liu, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems